AZENTA, INC. (AZTA) FY2026 Q3 P&L / Income Statement

AZENTA, INC. (AZTA) FY2026 Q3 P&L / Income Statement

Income statement for 2026-04-01 through 2026-06-30. View: Business segment (3 categories). Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Total revenue

161,178,000 US dollars

Total cost of revenue

88,822,000 US dollars

Gross profit

72,356,000 US dollars

Total operating expenses

76,534,000 US dollars

Operating loss

negative 4,178,000 US dollars

Other income (expense), net (calculated)

5,024,000 US dollars

Income (loss) from continuing operations before income taxes

846,000 US dollars

Income tax expense

2,375,000 US dollars

Net income (loss)

2,456,000 US dollars

Multiomics

72,889,000 US dollars

Core Products

47,682,000 US dollars

Sample Repository Services

40,607,000 US dollars

Research and development

8,853,000 US dollars

Selling, general and administrative

67,168,000 US dollars

Impairment of goodwill and intangible assets

0 US dollars

Restructuring charges

513,000 US dollars

Income (loss) from discontinued operations, net of tax

3,985,000 US dollars. Reported below-tax contribution to net income.

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit, plus the explicitly reported below-tax contributions, equals net income.